Imagion Biosystems Limited (ASX: IBX) is pleased to announce it has become a member of the Nanosystems Engineering Research Center at Boston University, where researchers are developing ultrasensitive magnetic sensors that could greatly simplify the MagSense® detection system. If successful, the new sensors could enable the use of MagSense cancer detection technology in a doctor’s suite in addition to a hospital imaging suite.
Read the announcement: Imagion to work with Boston University on next generation imaging technology.
